BioNexus Gene Lab Corp. Share Price

Equities

BGLC

US0906282076

Healthcare Facilities & Services

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
0.5935 USD +0.15% Intraday chart for BioNexus Gene Lab Corp. -1.05% +11.98%
Sales 2022 10.93M 875M Sales 2023 9.77M 782M Capitalization 9.36M 750M
Net income 2022 - 0 Net income 2023 -2M -160M EV / Sales 2022 14.9 x
Net cash position 2022 2.06M 165M Net cash position 2023 5.78M 463M EV / Sales 2023 0.37 x
P/E ratio 2022
-461 x
P/E ratio 2023
-3.2 x
Employees 30
Yield 2022 *
-
Yield 2023
-
Free-Float 35.63%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.15%
1 week-1.05%
Current month-15.93%
1 month-15.21%
3 months+11.98%
6 months+45.75%
Current year+11.98%
More quotes
1 week
0.58
Extreme 0.58
0.68
1 month
0.58
Extreme 0.58
1.00
Current year
0.40
Extreme 0.4004
3.39
1 year
0.31
Extreme 0.31
17.88
3 years
0.31
Extreme 0.31
27.00
5 years
0.31
Extreme 0.31
41.40
10 years
0.31
Extreme 0.31
41.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 31/07/23
Members of the board TitleAgeSince
Director/Board Member 68 06/03/22
Director/Board Member 48 12-10
Chief Executive Officer 40 31/07/23
More insiders
Date Price Change Volume
26/04/24 0.5935 +0.15% 37,932
25/04/24 0.5926 -0.40% 44,884
24/04/24 0.595 +2.23% 56,993
23/04/24 0.582 -6.13% 156,866
22/04/24 0.62 +3.37% 295,592

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
BioNexus Gene Lab Corp., through its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd., focuses on the wholesale of chemical raw material products. The Company is engaged in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. The Company is also engaged in the business of developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. Its non-invasive blood screening tests analyze changes in ribonucleic acid (RNA) to detect the risk potentiality of approximately 11 different diseases. It offers a range of fiberglass reinforced plastic (FRP) products, which include Polyester Resin SHCP 268, Polyester Resin 9509 and Polyester Resin 2802. The FRP and other raw materials it offers are used to produce a variety of goods, including handrails, bench tops, cleanroom panels, and covers for various instruments used in manufacturing.
More about the company